Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases von Ha, Helen, Debnath, Bikash, Neamati, Nouri

Volltext

2,3-Dihydroquinazolin-4(1H)-one as a privileged scaffold in drug design von Badolato, Mariateresa, Aiello, Francesca, Neamati, Nouri

Volltext

Why All the Fuss about Oxidative Phosphorylation (OXPHOS)? von Xu, Yibin, Xue, Ding, Bankhead, Armand, Neamati, Nouri

Volltext

Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein von Debnath, Bikash, Xu, Shili, Neamati, Nouri

Volltext

Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer von Madak, Joseph T., Bankhead, Armand, Cuthbertson, Christine R., Showalter, Hollis D., Neamati, Nouri

Volltext

Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism von Pathania, Divya, Millard, Melissa, Neamati, Nouri

Volltext

Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer von Xu, Shili, Grande, Fedora, Garofalo, Antonio, Neamati, Nouri

Volltext

Small molecule inhibitors of CXCR4 von Debnath, Bikash, Xu, Shili, Grande, Fedora, Garofalo, Antonio, Neamati, Nouri

Volltext

Multiparameter Optimization of Oxidative Phosphorylation Inhibitors for the Treatment of Pancreatic Cancer von Xue, Ding, Xu, Yibin, Kyani, Armita, Roy, Joyeeta, Dai, Lipeng, Sun, Duxin, Neamati, Nouri

Volltext

Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth von McLean, Karen, Tan, Lijun, Bolland, Danielle E., Coffman, Lan G., Peterson, Luke F., Talpaz, Moshe, Neamati, Nouri, Buckanovich, Ronald J.

Volltext

Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy von Lee, Yonghyun, Shinn, Jongyoon, Xu, Cheng, Dobson, Hannah E., Neamati, Nouri, Moon, James J.

Volltext

Discovery and Lead Optimization of Benzene-1,4-disulfonamides as Oxidative Phosphorylation Inhibitors von Xue, Ding, Xu, Yibin, Kyani, Armita, Roy, Joyeeta, Dai, Lipeng, Sun, Duxin, Neamati, Nouri

Volltext

Integrin targeted therapeutics von Millard, Melissa, Odde, Srinivas, Neamati, Nouri

Volltext

Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma von Samanta, Soma, Tamura, Shuzo, Dubeau, Louis, Mhawech-Fauceglia, Paulette, Miyagi, Yohei, Kato, Hisamori, Lieberman, Rich, Buckanovich, Ronald J., Lin, Yvonne G., Neamati, Nouri

Volltext

Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3 von Lu, Tiangong, Bankhead, 3rd, Armand, Ljungman, Mats, Neamati, Nouri

Volltext

In Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered Cyclotide von Ji, Yanbin, Majumder, Subhabrata, Millard, Melissa, Borra, Radhika, Bi, Tao, Elnagar, Ahmed Y, Neamati, Nouri, Shekhtman, Alexander, Camarero, Julio A

Volltext

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors von Serrao, Erik, Odde, Srinivas, Ramkumar, Kavya, Neamati, Nouri

Volltext

Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment von Xu, Shili, Butkevich, Alexey N, Yamada, Roppei, Zhou, Yu, Debnath, Bikash, Duncan, Roger, Zandi, Ebrahim, Petasis, Nicos A, Neamati, Nouri

Volltext

Advances Toward COVID-19 Therapies Special Issue von Neamati, Nouri

Volltext

GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors von Yamamoto, Vicky, Ha, Dat P., Liu, Ze, Huang, Miller, Samanta, Soma, Neamati, Nouri, Lee, Amy S.

Volltext